Matt Coffey, Ph.D., is the former CEO of Oncolytics Biotech, a biotechnology company focused on developing the immunotherapeutic agent pelareorep for cancer.
Matt Coffey, Ph.D., is the former CEO of Oncolytics Biotech, a biotechnology company focused on developing the immunotherapeutic agent pelareorep for cancer treatment. He was recognized with the Scientific Achievement and Innovation Award by BioAlberta for his contributions to scientific advancement and innovation.
Full founder directory · Investor directory · Company funding database · Fundraising library